[go: up one dir, main page]

DE69918946D1 - Rezeptoren für il-18 - Google Patents

Rezeptoren für il-18

Info

Publication number
DE69918946D1
DE69918946D1 DE69918946T DE69918946T DE69918946D1 DE 69918946 D1 DE69918946 D1 DE 69918946D1 DE 69918946 T DE69918946 T DE 69918946T DE 69918946 T DE69918946 T DE 69918946T DE 69918946 D1 DE69918946 D1 DE 69918946D1
Authority
DE
Germany
Prior art keywords
receptor
polypeptide
receptors
multimeric
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69918946T
Other languages
English (en)
Other versions
DE69918946T2 (de
Inventor
E Sims
L Born
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of DE69918946D1 publication Critical patent/DE69918946D1/de
Application granted granted Critical
Publication of DE69918946T2 publication Critical patent/DE69918946T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69918946T 1998-01-23 1999-01-22 Rezeptoren für il-18 Expired - Lifetime DE69918946T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US7230198P 1998-01-23 1998-01-23
US72301P 1998-01-23
US7883598P 1998-03-20 1998-03-20
US78835P 1998-03-20
US9446998P 1998-07-28 1998-07-28
US94469P 1998-07-28
PCT/US1999/001419 WO1999037772A1 (en) 1998-01-23 1999-01-22 Il-18 receptors

Publications (2)

Publication Number Publication Date
DE69918946D1 true DE69918946D1 (de) 2004-09-02
DE69918946T2 DE69918946T2 (de) 2005-07-28

Family

ID=27372056

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918946T Expired - Lifetime DE69918946T2 (de) 1998-01-23 1999-01-22 Rezeptoren für il-18

Country Status (13)

Country Link
US (4) US6589764B1 (de)
EP (1) EP1047781B1 (de)
JP (1) JP4271850B2 (de)
AT (1) ATE272114T1 (de)
AU (1) AU737592B2 (de)
CA (1) CA2318482C (de)
DE (1) DE69918946T2 (de)
DK (1) DK1047781T3 (de)
ES (1) ES2226335T3 (de)
IL (2) IL137178A0 (de)
NZ (1) NZ505880A (de)
PT (1) PT1047781E (de)
WO (1) WO1999037772A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US7083949B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US20020155526A1 (en) 1998-09-30 2002-10-24 Busfield Samantha J. Novel secreted immunomodulatory proteins and uses thereof
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
AU783473B2 (en) 1999-12-23 2005-10-27 Zymogenetics Inc. Soluble interleukin-20 receptor
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
KR20110032012A (ko) 2000-02-10 2011-03-29 아보트 러보러터리즈 사람 인터류킨-１８에 결합하는 항체 및 이를 제조하고 사용하는 방법
US20020052475A1 (en) * 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor
US20020025317A1 (en) * 2000-07-20 2002-02-28 Schering Ag Bispecific monoclonal antibodies to IL-12 and IL-18
EP2177616B1 (de) 2000-08-08 2012-02-29 ZymoGenetics, Inc. Lösliche Zcyctor 11 Cytokinrezeptoren
ES2267814T3 (es) 2000-09-15 2007-03-16 Zymogenetics, Inc. Metodo para tratar la inflamacion.
EP1331943A4 (de) * 2000-10-11 2005-01-26 Viron Therapeutics Inc Nukleinsäure-moleküle und polypeptide zur immunmodulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
GB2375604A (en) * 2001-05-18 2002-11-20 Warner Lambert Co Methods for screening using interleukin soluble trimolecular complex
EP2087908B1 (de) 2001-06-26 2018-05-30 Amgen Inc. Antikörper gegen opgl
EP1293566A1 (de) * 2001-09-17 2003-03-19 Societe Des Produits Nestle S.A. Ein löslicher Toll-ähnlicher Rezeptor
AU2002357283B2 (en) 2001-12-17 2007-08-16 Zymogenetics, Inc. Method for treating cervical cancer
AU2003259995B2 (en) 2002-08-28 2009-07-02 Immunex Corporation Compositions and methods for treating cardiovascular disease
EA008667B1 (ru) 2002-10-08 2007-06-29 Арес Трейдинг С.А. Применение цитокина, способного связывать il-18bp и ингибировать активность второго цитокина
JP2007525438A (ja) 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
WO2005052000A2 (en) 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation
US7141382B1 (en) 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
KR101238684B1 (ko) 2004-10-22 2013-03-04 지모제넥틱스, 인코포레이티드 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에서의사용방법
JP2008529505A (ja) * 2005-02-15 2008-08-07 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
US20080292590A1 (en) * 2006-02-22 2008-11-27 Burkhard Becher Soluble Receptors and Methods for Treating Autoimmune or Demyelinating Diseases
ATE555383T1 (de) 2006-06-22 2012-05-15 Novo Nordisk As Lösliche heterodimere rezeptoren und ihre verwendung
US20090252729A1 (en) * 2007-05-14 2009-10-08 Farrington Graham K Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9795674B2 (en) 2010-02-26 2017-10-24 Novo Nordisk A/S Stable antibody containing compositions
RS66182B1 (sr) 2010-05-28 2024-12-31 Novo Nordisk As Stabilne višedozne kompozicije koje sadrže antitelo i konzervans
SI2591006T1 (sl) 2010-07-09 2019-10-30 Bioverativ Therapeutics Inc Enoverižne molekule, ki jih lahko obdelujemo in polipeptidi izdelani z njihovo uporabo
MX340555B (es) 2010-08-25 2016-07-14 F Hoffmann-La Roche Ag * Anticuerpos contra il-18r1 y usos de los mismos.
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
EP0533006A1 (de) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimäre Interleukin 5-Rezeptor/Immunoglobulin-Polypeptide
US5470952A (en) 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
WO1996013593A2 (en) * 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
US5853721A (en) 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
PT1243597E (pt) * 1995-08-01 2008-10-17 Hoffmann La Roche Receptores para interleucina-12 humana
US5776731A (en) 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US6280955B1 (en) * 1997-12-16 2001-08-28 Tularik Inc. Interleukin-1 receptor accessory proteins, nucleic acids and methods
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US20020052475A1 (en) 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor

Also Published As

Publication number Publication date
IL137178A (en) 2007-06-17
EP1047781B1 (de) 2004-07-28
US7704945B2 (en) 2010-04-27
CA2318482C (en) 2010-04-13
US8053233B2 (en) 2011-11-08
US20070135625A1 (en) 2007-06-14
DE69918946T2 (de) 2005-07-28
AU737592B2 (en) 2001-08-23
ES2226335T3 (es) 2005-03-16
PT1047781E (pt) 2004-11-30
US20030199040A1 (en) 2003-10-23
JP4271850B2 (ja) 2009-06-03
IL137178A0 (en) 2001-07-24
US7169581B2 (en) 2007-01-30
JP2002500886A (ja) 2002-01-15
EP1047781A1 (de) 2000-11-02
US20100190211A1 (en) 2010-07-29
ATE272114T1 (de) 2004-08-15
AU2466899A (en) 1999-08-09
CA2318482A1 (en) 1999-07-29
WO1999037772A1 (en) 1999-07-29
US6589764B1 (en) 2003-07-08
DK1047781T3 (da) 2004-12-06
NZ505880A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ATE272114T1 (de) Rezeptoren für il-18
ATE346869T1 (de) Agonistische antikörper gegen tie2
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
PT1421115E (pt) Receptor de celulas t soluvel
FI972390A0 (fi) Sytokiini nimeltä Lerk-7
ES2304795T3 (es) Anticuerpos agonistas para el receptor de trombopoyetina y sus usos terapeuticos.
DE69837606D1 (de) Cystein-reiche rezeptoren-train
DK1584683T3 (da) Human G-protein-koblet orphan receptor RUP3
AR030504A1 (es) Peptidos ciclicos selectivos
DE69709561D1 (de) Östrogen-Rezeptor
PT694042E (pt) Inibidor do factor de crescimento de celulas endoteliais vasculares
DE60142794D1 (de) Antikörper gegen cd28
IT1307900B1 (it) Antagonisti iii del recettore ccr-3.
AUPO755097A0 (en) Receptor agonist and antagonist
DK1316801T3 (da) Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer
HRP20050354B1 (de)
IT1307062B1 (it) Antagonisti iii del recettore ccr-3.
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
ATE272632T1 (de) Muskarin-rezeptor antagonisten
EP0684823A4 (de) Fibrinogenrezeptorantagonisten.
DE59801230D1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
TR200200357T2 (tr) Yeni integrin reseptör antagonistleri
ATE429496T1 (de) Gpr54 'knock-out' säugetiere und screening- verfahren, die sie verwenden
BR0010843A (pt) Antagonistas de receptores de il-8
EP0862627A4 (de) Rezeptor des y-y5 neuropeptids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOCKHORNI & KOLLEGEN, 80687 MUENCHEN